Cell type-specific over-expression of chromosome 21 genes in fibroblasts and fetal hearts with trisomy 21
2006

Over-expression of chromosome 21 genes in Down syndrome

Sample size: 11 publication Evidence: moderate

Author Information

Author(s): Li Chi-Ming, Guo Meirong, Salas Martha, Schupf Nicole, Silverman Wayne, Zigman Warren B, Husain Sameera, Warburton Dorothy, Thaker Harshwardhan, Tycko Benjamin

Primary Institution: Columbia University College of Physicians and Surgeons

Hypothesis

Different subsets of chromosome 21 genes are over-expressed in different cell types with trisomy 21.

Conclusion

Different subsets of chromosome 21 genes are over-expressed in different cell types with trisomy 21, and hyperactive interferon signaling may contribute to cell senescence and autoimmune disorders in Down syndrome.

Supporting Evidence

  • MX1 gene was strongly over-expressed (mean 16-fold) in senescent +21 fibroblasts.
  • GART gene showed strong over-expression (mean 3-fold) in fetal hearts with +21.
  • Interferon signaling was suggested as a pathway for the over-expression of certain genes.

Takeaway

This study found that certain genes on chromosome 21 are more active in people with Down syndrome, which might help explain some of the health issues they face.

Methodology

The study used oligonucleotide microarrays to analyze mRNA expression in fibroblasts and fetal hearts, supplemented with northern blotting, western blotting, real-time RT-PCR, and immunohistochemistry.

Limitations

The study did not correct statistically for multiple comparisons, which may affect the power to detect changes.

Participant Demographics

Five normal and six Down syndrome skin fibroblasts were used, along with fetal hearts from cases of trisomy 21.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2350-7-24

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication